Immunology and Microbiology
Transplant Procedure
100%
Human Leukocyte Antigen
93%
Epstein Barr Virus
64%
Kidney Transplantation
61%
HLA Antibody
51%
Monospecific Antibody
42%
Lung Transplantation
37%
Allele
36%
T Cell
33%
Allotransplantation
32%
Haplotype
32%
Immune Complex
28%
Liver Transplantation
24%
Single Nucleotide Polymorphism
23%
Epitope
23%
Antigen Expression
18%
Immune Response
17%
Prevalence
15%
HLA Antigen
15%
Blood Plasma
15%
Solid Organ Transplantation
14%
Complement Activation
13%
Complement Lectin Pathway
13%
Immunosuppression
13%
Antibody Mediated Rejection
13%
Promoter Region
12%
Precursor
12%
Cytotoxic T Cell
12%
DNA Virus
12%
Lectin Pathway
10%
Immunosuppressive Drug
10%
Transplantation Tolerance
9%
Acute Graft Rejection
9%
B Cell
9%
T Helper Cell
9%
Tacrolimus
8%
Immunoassay
8%
Gene Frequency
8%
Bronchiolitis
7%
Mannose Binding Lectin
7%
Tumor Cell
7%
Solid
7%
Secretion (Process)
6%
CD4
6%
ANCA Associated Vasculitis
6%
Inflammation Response
6%
Complement Component C3d
6%
CCR5
6%
Antigen-Presenting Cell
6%
Endoplasmic reticulum
6%
Medicine and Dentistry
Kidney Graft
68%
Epstein Barr Virus
33%
Classical Hodgkin Lymphoma
31%
Quality of Life
30%
Kidney Transplantation
26%
Liver Transplantation
24%
Lung Transplantation
24%
Human Leukocyte Antigen
22%
Graft Failure
20%
HLA Antibody
20%
Allele
18%
Graft Survival
17%
Endothelial Cell
15%
Transplantation
15%
Cohort Analysis
14%
T Cell
13%
Bacterial Infection
12%
Precursor
12%
Cytotoxic T-Cell
12%
Complement Component C3d
12%
Antibody Mediated Rejection
11%
Hazard Ratio
11%
Transplantation Tolerance
9%
Haplotype
9%
Allograft
9%
Kidney Function
9%
End Stage Renal Disease
8%
Tumor Cell
8%
Antibodies
8%
Bronchiolitis Obliterans
8%
Kidney Allograft
8%
Chronic Kidney Disease
7%
Genetic Variability
7%
Complement Lectin Pathway
7%
Mannose Binding Lectin
7%
Creatinine
7%
Pediatrics
6%
Genome Wide Association Study
6%
Nephropathy
6%
Immunosuppressive Treatment
6%
Infection
6%
Iron Deficiency
6%
HLA-A
6%
Epstein-Barr Virus
6%
Gene Locus
6%
Systematic Review
6%
Cytotoxicity Assay
6%
Amino Terminal Sequence
6%
Fibrosis
6%
Cohort Effect
6%
Keyphrases
Kidney Transplant Recipients
43%
Human Leukocyte Antigen
36%
Health-related Quality of Life
28%
Human Leukocyte Antigen Antibodies
18%
Classical Hodgkin Lymphoma
18%
Biobank
14%
Lymphoma Patients
14%
Human Leukocyte Antigen Class II
12%
Epstein-Barr Virus
10%
Solid Organ Transplantation
9%
Transplantation
9%
Pretransplant
9%
PIRCHE
9%
Kidney Transplantation
9%
Antibody Assay
8%
HLA Class II
7%
Phenotypic Mismatch
7%
HLA Antibodies
7%
Single Antigen Bead
7%
New Human Leukocyte Antigen Allele
7%
Surrogate Marker
7%
HLA Class II Alleles
7%
Donor-recipient Matching
7%
Human Leukocyte Antigen Class I
7%
Deceased Donor Transplant
7%
Iron Deficiency
6%
Calciprotein Particles
6%
Vascular Remodeling
6%
Chronic Kidney Disease
6%
Particle Counting
6%
Type-directed
6%
HLA-DR4
6%
Graft Outcome
6%
Renal Transplant
6%
Lymphoproliferative Disorders
6%
HLA-B
6%
Promoter Haplotypes
6%
Load Monitoring
6%
Epstein-Barr Virus DNA Load
6%
HLA Antigens
6%
B-matching
6%
Allele Polymorphism
6%
Genetic Loci
6%
Human Leukocyte Antigen Haplotype
6%
Post-transplant Lymphoproliferative Disorder
6%
HLA-A*02
6%
Interleukin-10 Gene
6%
Experimental Human Endotoxemia
6%
Gene Promoter Polymorphism
6%
CD58
6%
